350 related articles for article (PubMed ID: 28068369)
1. Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
Lee LH; Hwang JI; Cheng YC; Wu CY; Lee SW; Yang SS; Yeh HZ; Chang CS; Lee TY
PLoS One; 2017; 12(1):e0169655. PubMed ID: 28068369
[TBL] [Abstract][Full Text] [Related]
2. Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma.
Wu CH; Liang PC; Su TH; Lin MC; Chang YH; Shih TT; Kao JH
Hepatol Int; 2021 Oct; 15(5):1247-1257. PubMed ID: 34338971
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound.
Zhang W; Luo E; Gan J; Song X; Bao Z; Zhang H; Chen M
World J Surg Oncol; 2017 Jul; 15(1):122. PubMed ID: 28679433
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ultrasound-, computed tomography-, and magnetic resonance imaging-guided radiofrequency ablation for hepatocellular carcinoma.
Yuan C; Yuan Z; Cui X; Gao W; Zhao P; He N; Cui S; Wang Y; Zhang Y; Li W; Zheng J
J Cancer Res Ther; 2019; 15(4):784-792. PubMed ID: 31436232
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.
Yang W; Yan K; Wu GX; Wu W; Fu Y; Lee JC; Zhang ZY; Wang S; Chen MH
World J Gastroenterol; 2015 Feb; 21(5):1554-66. PubMed ID: 25663774
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
Kawamura Y; Ikeda K; Seko Y; Hosaka T; Kobayashi M; Saitoh S; Kumada H
AJR Am J Roentgenol; 2011 Oct; 197(4):W665-73. PubMed ID: 21940538
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effectiveness and safety of ultrasound- and CT-guided percutaneous radiofrequency ablation of non-operation hepatocellular carcinoma.
Wu J; Chen P; Xie YG; Gong NM; Sun LL; Sun CF
Pathol Oncol Res; 2015 Jul; 21(3):637-42. PubMed ID: 25466642
[TBL] [Abstract][Full Text] [Related]
9. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
[TBL] [Abstract][Full Text] [Related]
10. A comparison of US-guided percutaneous radiofrequency ablation of medium-sized hepatocellular carcinoma with a cluster electrode or a single electrode with a multiple overlapping ablation technique.
Park MJ; Kim YS; Rhim H; Lim HK; Lee MW; Choi D
J Vasc Interv Radiol; 2011 Jun; 22(6):771-9. PubMed ID: 21616430
[TBL] [Abstract][Full Text] [Related]
11. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
13. CT-guided versus laparoscopic radiofrequency ablation in recurrent small hepatocellular carcinoma against the diaphragmatic dome.
Ding H; Su M; Zhu C; Wang L; Zheng Q; Wan Y
Sci Rep; 2017 Mar; 7():44583. PubMed ID: 28291254
[TBL] [Abstract][Full Text] [Related]
14. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
[TBL] [Abstract][Full Text] [Related]
16. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma.
Huo J; Aloia TA; Xu Y; Chung TH; Sheu T; Tina Shih YC
Value Health; 2019 Mar; 22(3):284-292. PubMed ID: 30832966
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.
Choi D; Lim HK; Rhim H; Kim YS; Yoo BC; Paik SW; Joh JW; Park CK
Ann Surg Oncol; 2007 Aug; 14(8):2319-29. PubMed ID: 17522947
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of radiofrequency ablation for perivascular hepatocellular carcinoma without hepatic inflow occlusion.
Ng KK; Poon RT; Lam CM; Yuen J; Tso WK; Fan ST
Br J Surg; 2006 Apr; 93(4):440-7. PubMed ID: 16470712
[TBL] [Abstract][Full Text] [Related]
20. C-Arm Cone Beam Computed Tomography Guidance for Radiofrequency Ablation in Hepatocellular Carcinoma.
Kato K; Abe H; Ika M; Yonezawa T; Sato Y; Hanawa N; Shimizu S; Endo S; Matsuo R; Tsubota A
Oncology; 2017; 92(3):142-152. PubMed ID: 28052301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
